Home Cart 0 Sign in  
X

[ CAS No. 344-25-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 344-25-2
Chemical Structure| 344-25-2
Chemical Structure| 344-25-2
Structure of 344-25-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 344-25-2 ]

Related Doc. of [ 344-25-2 ]

Alternatived Products of [ 344-25-2 ]

Product Details of [ 344-25-2 ]

CAS No. :344-25-2 MDL No. :MFCD00064317
Formula : C5H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ONIBWKKTOPOVIA-SCSAIBSYSA-N
M.W : 115.13 Pubchem ID :8988
Synonyms :
(+)-(R)-Proline;(R)-(+)-Proline;(R)-Proline;(R)-2-Carboxypyrrolidine

Calculated chemistry of [ 344-25-2 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 32.52
TPSA : 49.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.84
Log Po/w (XLOGP3) : -2.5
Log Po/w (WLOGP) : -0.56
Log Po/w (MLOGP) : -2.59
Log Po/w (SILICOS-IT) : 0.22
Consensus Log Po/w : -0.92

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 1.09
Solubility : 1410.0 mg/ml ; 12.2 mol/l
Class : Highly soluble
Log S (Ali) : 2.01
Solubility : 11700.0 mg/ml ; 102.0 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.13
Solubility : 85.7 mg/ml ; 0.745 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.54

Safety of [ 344-25-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 344-25-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 344-25-2 ]
  • Downstream synthetic route of [ 344-25-2 ]

[ 344-25-2 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 344-25-2 ]
  • [ 62937-45-5 ]
Reference: [1] Journal of Pharmaceutical Sciences, 1991, vol. 80, # 9, p. 837 - 842
  • 2
  • [ 501-53-1 ]
  • [ 344-25-2 ]
  • [ 6404-31-5 ]
YieldReaction ConditionsOperation in experiment
93% With sodium hydroxide In water at 0 - 20℃; Step-1 : Preparation of (R)-l-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid (12a) To a stirred solution of D-Proline (1.2 g, 10.42 mmol) in 2 N aqueous NaOH solution (20.85 mL, 41.7 mmol) at 0 °C was added benzyl chloroformate (1.488 mL, 10.42 mmol) and allowed to warm to room temperature overnight. The reaction was washed with MTBE (2 x 25 mL), acidified with cone HCl and extracted with ethyl acetate (2 x 200 mL). The ethyl acetate layers were combined washed with water (50 mL), brine (25 mL) dried and concentrated in vacuum to afford (R)-l-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid (12a) (2.41 g, 9.67 mmol, 93 percent yield) which was used as such in next step; Η NMR (300 MHz, DMSO-i) δ 12.66 (s, 1H), 7.42 - 7.25 (m, 5H), 5.14 - 4.97 (m, 2H), 4.20 (ddd, J = 22.7, 8.8, 3.5 Hz, 1H), 3.50 - 3.25 (m, 2H), 2.32 - 2.08 (m, 1H), 1.97 - 1.75 (m, 3H); MS (ES+) 250.2 (M+l), 272.2 (M+Na), (ES-) 248.2 (M-l), 284.2 (M+Cl), 497.4 (2M-1).
Reference: [1] Patent: WO2015/62486, 2015, A1, . Location in patent: Paragraph 00191
[2] Patent: WO2017/59178, 2017, A1, . Location in patent: Page/Page column 73
[3] Journal of Pharmaceutical Sciences, 1991, vol. 80, # 9, p. 837 - 842
[4] Angewandte Chemie - International Edition, 2006, vol. 45, # 28, p. 4593 - 4597
[5] European Journal of Medicinal Chemistry, 2009, vol. 44, # 7, p. 2807 - 2814
  • 3
  • [ 99464-81-0 ]
  • [ 344-25-2 ]
  • [ 6404-31-5 ]
Reference: [1] Synthesis, 1986, # 8, p. 627 - 632
  • 4
  • [ 13139-17-8 ]
  • [ 344-25-2 ]
  • [ 6404-31-5 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 11, p. 3849 - 3856
  • 5
  • [ 78-59-1 ]
  • [ 344-25-2 ]
  • [ 873-94-9 ]
Reference: [1] Catalysis Science and Technology, 2015, vol. 5, # 2, p. 716 - 723
  • 6
  • [ 344-25-2 ]
  • [ 68832-13-3 ]
Reference: [1] Patent: US5130432, 1992, A,
[2] Organic Syntheses, 1987, vol. 65, p. 173 - 173
[3] Tetrahedron Asymmetry, 2017, vol. 28, # 4, p. 511 - 515
  • 7
  • [ 344-25-2 ]
  • [ 73365-02-3 ]
Reference: [1] Patent: US2011/263561, 2011, A1,
[2] Nature, 2014, vol. 509, # 7500, p. 318 - 324
  • 8
  • [ 344-25-2 ]
  • [ 53912-80-4 ]
Reference: [1] Tetrahedron, 2011, vol. 67, # 7, p. 1485 - 1500
  • 9
  • [ 344-25-2 ]
  • [ 72748-99-3 ]
Reference: [1] Organic Syntheses, 1987, vol. 65, p. 173 - 173
  • 10
  • [ 100-44-7 ]
  • [ 344-25-2 ]
  • [ 56080-99-0 ]
YieldReaction ConditionsOperation in experiment
79% With potassium hydroxide In isopropyl alcohol at 40℃; for 6 h; A suspension of D-proline (115 g, 1 mol), potassium hydroxide (168.3 g, 3 mol), and isopropylalcohol (1L) was stirred at 40 °C until the suspension became transparent. Next, 137.3 g (1. 1 mol) of benzylchloride was slowly added thereto and stirred at 40 °C for 6 hours. The reaction mixture was cooled to 0 ~ 5 °C and adjusted to pH 5-6 using 145 mL of conc. HC1. The reaction mixture was diluted using 3 L of chloroform and stirred for 18 hours. Potassium chloride was removed from the reaction mixture by filtration, and the filtrate was concentrated and recrystallized using acetone to obtain the subtitled compound with a yield of 79percent (161.8 g). [39] 1H-NMR(CDCl3, ppm): 6 7. 2-7. 4 (m, 5H), 4. 0-4. 4 (dd, 2H), 3.8 (dd, 1H), 3. 6- 3.7 (m, 1H), 2.8 (dd, 1H), 1. 8-2. 4 (m, 4H) [40] [α]D25 =+ 28. 4 (c = 1, EtOH) [41] Melting point = 174-175 °C
79% With potassium hydroxide In isopropyl alcohol at 40℃; for 6 h; A suspension of D-proline (115 g, 1 mol), potassium hydroxide (168.3 g, 3 mol), and isopropylalcohol (1 L) was stirred at 40° C. until the suspension became transparent. Next, 137.3 g (1.1 mol) of benzylchloride was slowly added thereto and stirred at 40° C. for 6 hours. The reaction mixture was cooled to 0-5° C. and adjusted to pH 5-6 using 145 mL of conc. HCl. The reaction mixture was diluted using 3 L of chloroform and stirred for 18 hours. Potassium chloride was removed from the reaction mixture by filtration, and the filtrate was concentrated and recrystallized using acetone to obtain the compound 2 with a yield of 79percent (161.8 g).
52 g With potassium hydroxide In isopropyl alcohol at 0℃; To a stirred solution of (R)-pyrrolidine-2-carboxylic acid (57.7 g, 0.5 mol) and KOH (84 g, 1.5 mol) in isopropyl alcohol (330 mL) was added benzyl chloride (70 mL, 0.6 mol) dropwise at 0° C. over 3 hours. The mixture was then stirred overnight at the same temperature. The resulting mixture was neutralized with concentrate HCl to pH=6, followed by the addition of chloroform (200 mL). The mixture was stirred for 30 minutes, then filtered and the precipitate was washed with chloroform (3×100 mL). The combined chloroform solutions were dried over anhydrous Na2SO4, and concentrated under vacuum to yield Compound 3 (52 g) as a white solid. LC-MS: 206 [M+H]+.
52 g With potassium hydroxide In isopropyl alcohol at 0℃; To a stirred solution of (R)-pyrrolidine-2-carboxylic acid (57.7 g, 0.5 mol) and KOH (84 g, 1.5 mol) in isopropyl alcohol (330 mL) was added benzyl chloride (70 mL, 0.6 mol) dropwise at 0° C. over 3 hours. The mixture was then stirred overnight at the same temperature. The resulting mixture was neutralized with concentrate HCl to pH=6, followed by the addition of chloroform (200 mL). The mixture was stirred for 30 minutes, then filtered and the precipitate was washed with chloroform (100 mL×3). The combined chloroform solutions were dried over anhydrous Na2SO4, and concentrated under vacuum to yield Compound 3 (52 g) as a white solid. LC-MS: 206 [M+H]+.
52 g With potassium hydroxide In isopropyl alcohol at 0℃; Inert atmosphere [0292] To a stirred solution of(R)-pyrrolidine-2-carboxylicacid (57 .7 g, 0.5 mol) and KOH (84 g, 1.5 mol) in isopropylalcohol (330 mL) was added benzyl chloride (70 mL, 0.6 mol)dropwise at oo C. over 3 hours. The mixture was then stirredovernight at the same temperature. The resulting mixture wasneutralized with concentrated HCl to pH 6, followed by theaddition of chloroform (200 mL ). The mixture was stirred for30 minutes, then filtered and the precipitate was washed withchloroform (100 mLx3). The combined chloroform solutionswere dried over Na2S04 , and concentrated in vacuo to yieldCompound 3 (52 g) as a white solid. LC-MS: 206 [M+Ht.
52 g With potassium hydroxide In isopropyl alcohol at 0℃; To a stirred solution of (R)-pyrrolidine-2-carboxylic acid (57.7 g, 0.5 mol) and KOH (84 g, 1.5 mol) in isopropyl alcohol (330 mL) was added benzyl chloride (70 mL, 0.6 mol) dropwise at 0°C over 3 hours. The mixture was then stirred overnight at the same temperature. The resulting mixture was neutralized with concentrated HC1 to pH 6, followed by the addition of chloroform (200 mL). The mixture was stirred for 30 minutes, then filtered and the precipitate was washed with chloroform (100 mLx3). The combined chloroform solutions were dried over Na2S04, and concentrated in vacuo to yield (0492) Compound 3 (52 g) as a white solid. LC-MS: 206 [M+H]+.

Reference: [1] Patent: WO2005/85178, 2005, A1, . Location in patent: Page/Page column 7-8; 10-11
[2] Patent: JP2005/247828, 2005, A, . Location in patent: Page/Page column 15-16
[3] Patent: US2015/210667, 2015, A1, . Location in patent: Paragraph 0109; 0110
[4] Journal of Organic Chemistry, 1991, vol. 56, # 1, p. 442 - 444
[5] Patent: WO2011/138795, 2011, A2, . Location in patent: Page/Page column 25
[6] Patent: US2013/109639, 2013, A1, . Location in patent: Paragraph 0450
[7] Patent: US2014/256702, 2014, A1, . Location in patent: Paragraph 0298
[8] Angewandte Chemie - International Edition, 2014, vol. 53, # 31, p. 8150 - 8153
[9] Patent: US2015/210690, 2015, A1, . Location in patent: Paragraph 0231; 0292
[10] Patent: WO2015/116786, 2015, A1, . Location in patent: Paragraph 77
  • 11
  • [ 100-39-0 ]
  • [ 344-25-2 ]
  • [ 56080-99-0 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: With potassium hydroxide In isopropyl alcohol at 40℃;
Stage #2: With hydrogenchloride In chloroform; water; isopropyl alcohol at 20℃; for 12 h;
General procedure: To a solution of proline (2.0 g, 17 mmol) and KOH (2.85 g, 51 mmol) in i-PrOH (50 mL),4-substituted benzyl derivative (21 mmol) was added at 40° C. Afterwards, the mixture was stirred for8 h at 40° C and then the reaction mixture was cooled to room temperature. 6 M HCl was added toadjust the pH value of the mixture to 4–5 and then CHCl3 (50 mL) was added. The mixture was stirredfor 12 h, followed by filtration and evaporation in vacuo. The residue was purified by recrystallizationin acetone at 0° C to give 6 (about 90percent yield).
Reference: [1] Molecules, 2017, vol. 22, # 10,
  • 12
  • [ 344-25-2 ]
  • [ 113304-84-0 ]
Reference: [1] Tetrahedron, 2011, vol. 67, # 7, p. 1485 - 1500
  • 13
  • [ 344-25-2 ]
  • [ 73323-65-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 3, p. 551 - 556
  • 14
  • [ 344-25-2 ]
  • [ 35150-07-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 10, p. 3524 - 3548
  • 15
  • [ 344-25-2 ]
  • [ 96193-27-0 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1984, vol. 18, # 12, p. 811 - 815[2] Khimiko-Farmatsevticheskii Zhurnal, 1984, vol. 18, # 12, p. 1445 - 1448
  • 16
  • [ 24424-99-5 ]
  • [ 344-25-2 ]
  • [ 37784-17-1 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hydrogencarbonate In 1,4-dioxane; water at 20℃; for 0.5 h;
Stage #2: at 0 - 20℃;
Step- 1 : Synthesis of N-tert-butoxycarbonyl-(D)-Proline: [0264] To a stirred solution of D-proline (100 g, 868.58 mmol) in dioxane (400 mL, 8 vol) was added NaHC03 (182.4 g, 2.5 eq.) and water (800 mL, 8 vol) at room temperature and stirred the reaction mixture for about 30 minutes. The reaction mixture was cooled to 0- 5°C temperature and Di-tert-butyl dicarbonate (BOC)20 (224.26 g, 1.2 eq.) was added and stirred for 1 h at 0-5°C. Then the reaction mixture was warmed to room temperature and stirred for over night (12-16 hours). Reaction mixture was monitored by TLC, after completion of reaction, solvent dioxane was evaporated. The aqueous layer was acidified with 4N HC1 solution to PH 2 to 3 at 0-5 °C. The Aqueous layer was extracted with ethyl acetate (4X 200 mL) and combined organic layer was washed with water and dried over Na2S04. Organic layer was evaporated under reduced pressure to provide a white solid. The obtained white solid was taken in to heptane (200 mL) and stirred for about 2 hours at room temperature. Filtered the solid and dried the compound under vacuum at 45-50°C temperature (Wt: 125 g, Yield: 90-95percent). 1H NMR (300 MHz, CDC13): δ 9.20 (br, lH), 4.34 (t, 1H), 3.54- 3.13 (m, 2H), 2.31-2.25 (m, 1H), 2.09-1.88 (m, 3H), 1.48-1.42 (b, 9H); Mass: [M+Na]+ 238 (100percent).
Reference: [1] European Journal of Medicinal Chemistry, 2011, vol. 46, # 8, p. 3455 - 3461
[2] Patent: WO2014/105926, 2014, A1, . Location in patent: Paragraph 0264
[3] Synthetic Communications, 2009, vol. 39, # 18, p. 3243 - 3253
[4] Journal of Medicinal Chemistry, 1998, vol. 41, # 3, p. 284 - 290
[5] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 20, p. 2691 - 2696
[6] Patent: US4576749, 1986, A,
[7] Chirality, 2010, vol. 22, # 1, p. 173 - 181
[8] Journal of Medicinal Chemistry, 2011, vol. 54, # 10, p. 3524 - 3548
[9] Patent: US2011/263561, 2011, A1, . Location in patent: Page/Page column 15
[10] Journal of Organic Chemistry, 2014, vol. 79, # 6, p. 2694 - 2701
[11] Nature, 2014, vol. 509, # 7500, p. 318 - 324
[12] Tetrahedron, 2016, vol. 72, # 35, p. 5369 - 5376
[13] Patent: WO2017/17630, 2017, A1, . Location in patent: Page/Page column 49
  • 17
  • [ 344-25-2 ]
  • [ 37784-17-1 ]
Reference: [1] Patent: US5008245, 1991, A,
  • 18
  • [ 58632-95-4 ]
  • [ 344-25-2 ]
  • [ 37784-17-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 20, p. 3792 - 3798
  • 19
  • [ 344-25-2 ]
  • [ 60419-23-0 ]
Reference: [1] Patent: WO2017/17630, 2017, A1,
  • 20
  • [ 344-25-2 ]
  • [ 625471-18-3 ]
Reference: [1] Tetrahedron, 2011, vol. 67, # 7, p. 1485 - 1500
  • 21
  • [ 344-25-2 ]
  • [ 228244-04-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 10, p. 3524 - 3548
  • 22
  • [ 67-56-1 ]
  • [ 344-25-2 ]
  • [ 874964-22-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 36, p. 9398 - 9404
  • 23
  • [ 75-87-6 ]
  • [ 344-25-2 ]
  • [ 1263774-42-0 ]
YieldReaction ConditionsOperation in experiment
0.23 g at 20℃; for 8 h; To a solution of D-proline (0.4 g, 3.48 mmol) in MeCN (8 ml) the trifluoroacetaldehyde (0.68 ml, 6.94 mmol) was added and the resulting mixture was stirred at RT for 8 hrs. Solvents were evaporated and the residue was triturated with diethyl ether. After solvent filtration and drying, 0.23 g of title compound (D48) was isolated. MS: (ES/+) m/z: 244.0 [MH+] C7H8CI3N02 requires 242.96 1 H NMR (400MHz ,CHCI3-d) δ (ppm): 4.15 (dd, J = 4.5, 8.6 Hz, 1 H), 3.52 - 3.36 (m, J = 7.0, 7.0, 10.5 Hz, 1 H), 3.22 - 3.07 (m, 1 H), 2.33 - 2.20 (m, 1 H), 2.19 - 2.08 (m, 1 H), 1 .96 (quind, J = 5.9, 12.1 Hz, 1 H), 1 .84 - 1 .69 (m, 1 H), 1 .61 (br. s., 1 H).
0.23 g at 20℃; for 8 h; Description 1: (7aR)-3-(trichloromethyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one (D1) [0259] [0260] To a solution of D-proline (0.4 g, 3.48 mmol) in MeCN (8 ml) the trifluoroacetaldehyde (0.68 ml, 6.94 mmol) was added and the resulting mixture was stirred at RT for 8 hrs. Solvents were evaporated and the residue was triturated with diethyl ether. After solvent filtration and drying, 0.23 g of title compound (D1) was isolated. [0261] MS: (ES/+) m/z: 244.0 [MH+] C7H8Cl3NO2 requires 242.96 [0262] 1H NMR (400 MHz, CHCl3-d) δ (ppm): 4.15 (dd, J=4.5, 8.6 Hz, 1H), 3.52-3.36 (m, J=7.0, 7.0, 10.5 Hz, 1H), 3.22-3.07 (m, 1H), 2.33-2.20 (m, 1H), 2.19-2.08 (m, 1H), 1.96 (quind, J=5.9, 12.1 Hz, 1H), 1.84-1.69 (m, 1H), 1.61 (br. s., 1H).
0.23 g at 20℃; for 8 h; To a solution of D-proline (0.4 g, 3.48 mmol) in MeCN (8 ml) the trifluoroacetaldehyde (0.68 ml, 6.94 mmol) was added and the resulting mixture was stirred at RT for 8 hrs. Solvents were evaporated and the residue was triturated with diethyl ether. After solvent filtration and drying, 0.23 g of title compound (D48) was isolated.MS: (ES/+) m/z: 244.0 [MH+] C7H8Cl3NO2 requires 242.961H NMR (400 MHz, CHCl3-d) δ (ppm): 4.15 (dd, J=4.5, 8.6 Hz, 1H), 3.52-3.36 (m, J=7.0, 7.0, 10.5 Hz, 1H), 3.22-3.07 (m, 1H), 2.33-2.20 (m, 1H), 2.19-2.08 (m, 1H), 1.96 (quind, J=5.9, 12.1 Hz, 1H), 1.84-1.69 (m, 1H), 1.61 (br. s., 1H).
Reference: [1] Patent: US2011/136778, 2011, A1, . Location in patent: Page/Page column 54
[2] Patent: WO2013/4290, 2013, A1, . Location in patent: Page/Page column 66
[3] Patent: US2014/243373, 2014, A1, . Location in patent: Paragraph 0259-0261
[4] Patent: US2015/87626, 2015, A1, . Location in patent: Paragraph 0504; 0505; 0506; 0507
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 344-25-2 ]

Amino Acid Derivatives

Chemical Structure| 68078-09-1

[ 68078-09-1 ]

1-Methylpyrrolidine-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 475-11-6

[ 475-11-6 ]

H-N-Me-Pro-OH

Similarity: 0.95

Chemical Structure| 58123-62-9

[ 58123-62-9 ]

(R)-1-Methylpyrrolidine-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 3105-95-1

[ 3105-95-1 ]

(S)-Piperidine-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 1723-00-8

[ 1723-00-8 ]

H-D-HoPro-OH

Similarity: 0.95